Summary. Steady-state currents at hyperpolarized membrane potentials were studied in the homologous giant neurons, LP1 and R2, of Aplysia using two-electrode voltage clamp. Nearly half of the steady-state current at voltages more hyperpolarized than -70 mV had characteristics similar to the inwardly rectifying potassium current (In) described previously in Aplysia neurons. The pharmacological agents 4-bromophenacylbromide, indomethacin, and the phorbol ester, 12-O-tetradecanoyl-phorbol-13-acetate were found to modulate In. In was stimulated with BPB and indomethacin and inhibited with TPA. These agents altered In by a mechanism independent of cAMP, which can also modulate In. The effects of these modulators are consistent with their actions on arachidonic acid (AA) metabolism in Aplysia nervous system, suggesting AA may constitutively inhibit In. When ganglia were perfused for 12 hr with medium containing BSA to absorb extracellular fatty acids, IR was increased nearly twofold. This increase was partially inhibited by addition of AA to the perfusion medium, and completely inhibited by pretreatment of ganglia with BPB. Although no direct effect of shortterm exposure to exogenous AA was observed, long term exposure to exogenous AA and several other unsaturated fatty acids was accompanied by a decrease in IR.
Introduction
Arachidonic acid and its metabolites, or eicosanoids, have been shown to be involved in regulation of secretory processes. The role of eicosanoids in stimulus-secretion coupling in the anterior pituitary is one of the best characterized systems. Lipoxygenase and epoxygenase products have been implicated in the mediation of hormone-induced release of the pituitary hormones adrenocorticotropin hormone [1, 40, 43] , ~-endorphin [3, 45] , prolactin [8, 29, 43] , luteinizing hormone [15, 16, 28, 43] , and growth hormone [12, 13, 27, 43, 58] . The first direct demonstration that eicosanoids may regulate secretion through modulation of electrical activity came from work with identified neurons of the marine snail, Aplysia. At an identified synapse in Aplysia, eicosanoids have been implicated in the activation of a potassium current (S-current), which leads to inhibition of electrically-evoked transmitter release, or presynaptic inhibition [47, 48] . Modulation of potassium currents can alter cell excitability and thereby indirectly modulate neurotransmission or other secretory processes. Recently, several additional examples of AA-and eicosanoid-mediated modulation of potassium currents have been reported. Kim et al. [31] and Kurachi et al. [36] have implicated lipoxygenase metabolites in the regulation of muscarinic receptor-linked potassium channels. Also, AA ~ and other unsaturated fatty acids have been shown to directly activate potassium channels in ripped-off patches from heart [30] and smooth muscle cells [46] .
In the accompanying paper [11], we demonstrated constant turnover of intracellular free AA in Aplysia ganglia. This turnover was accompanied by a constant and substantial release of free AA and eicosanoids to the extraceUular medium. In this paper, we report our investigation of AA-mediated regulation of an inwardly rectifying potassium current in the giant neurons, LP1 and R2, of Aplysia. This current has previously been shown to be activated by serotonin [2, 6, 19] and Aplysia egg-laying hormone [39] , through the cAMP cascade. We 1Abbreviations: AA, arachidonic acid; AA-CoA, arachidonyl coenzyme A; TPA, 12-O-tetradecanoylphorbol 13-acetate; BPB, 4-bromophenacylbromide; PLA2, phospholipase Az; NDGA, nordihydroguaiaritic acid; 5HT, serotonin creatine sulfate; IBMX, isobutylmethylxanthine, DMSO, dimethylsulfoxide; IR, inwardly rectifying potassium current.
show now, using the pharmacological agents described in the accompanying paper and techniques which alter the amount of AA in lipid storage, that AA can also modulate IR, independent of cAMP.
Materials and Methods

ELECTROPHYSIOLOGY
Adult Aplysia californica (100 to 250 g) were supplied by Alacrity Marine Biological Services (Redondo Beach, CA). To anesthetize prior to dissection, Aplysia were injected with up to 100 ml of 0.4 M MgC12. Ganglia were removed and immediately placed in artificial seawater (ASW (control), in raM: 460 NaC1, 55 MgC12, 11 CaC12, 10 KC1, 10 NaHEPES, pH 7.3) with 1% (wt/ vol) glucose.
Ganglia were incubated in 1% (wt/vol) dispase in ASW for 1 hr at room temperature to loosen the connective tissue sheath prior to desheathing. Dispase was washed away and the abdominal or left pleural and connected left pedal ganglion, or "pleuropedal" ganglion, was pinned into a 0.5-ml chamber of Sylgard in a plastic petri dish. The ganglion was desheathed and placed under perfusion with ASW at about 1 ml/min. Perfusion was used to supply all pharmacological agents to the ganglion. DMSO was used to solubilize allagents used (except 5HT) prior to addition to ASW. The final concentration of DMSO in ASW was normally 0.05% (vol/vol), but as much as 0.25% DMSO was used to solubilize the highest concentrations of indomethacin tested. No discernible electrophysiological effects were observed for control solutions containing up to 0.25% DMSO.
The giant neuron (R2 in the abdominal ganglion or LP1 in the pleural ganglion) was impaled with two glass microelectrodes (1-4 M~2, filled with 0.5 M K2SO4) for intracellular recording and two-electrode voltage clamp. Two-electrode voltage clamp was performed with an Almost Perfect Electronics Voltage Clamp, a high-voltage Almost Perfect Electronics preamp (for current injection) and a W-P Instruments preamp (for monitoring voltage). Data were recorded on a Gould chart recorder and a four-channel Hewlett-Packard tape recorder for subsequent analysis. The giant neurons were clamped at -70 or -50 inV. Pulses from this holding potential to command potentials were used to generate current-voltage (l-V) curves. For command potentials more hyperpolarized than -30 mV, these pulses were normally 0.5 to 1 sec in duration. The current magnitude was measured at the end of the pulse and graphed as a function of command potential.
For experiments involving perfusion or dialysis and subsequent electrophysiological measurements over extended periods of time, aseptic cell culture techniques were employed. Ganglia were washed with several changes of sterile ASW, followed by incubation in a filter-sterilized solution of 1% (wt/vol) dispase in ASW for 2 hr. For extended perfusion, the sterile, dispasetreated abdominal and/or left pleuropedal ganglia, in groups of four to eight, were pinned to sterilized Sylgard-lined plastic 60-cm petri dishes, and desheathed using sterile instruments. The plate was then placed under perfusion with sterile, control ASW. The giant neurons were successively placed under voltage clamp, and the resting steady-state I-V curves were measured.
The plate was then placed under perfusion (-1 ml/min) for 12 hr with perfusion medium: sterile, dilute L15 (a nutrient medium from Flow Laboratories (McLean, VA); present at 20% of normal concentration) in ASW in penicillin (10 IU/ml), streptomycin (10/~g/ml), fungizone (amphotericin B, 0.5 k~g/ml) and 1% (wt/ vol) glucose. (Antibiotics were from Flow Laboratories.) This perfusion was carried out in a laminar flow hood. Then the plate was again placed under perfusion with control ASW, and the giant neuron steady-state I-V curves were measured.
For dialysis, the dispase-treated abdominal and/or left pleuropedal ganglia (with sheaths intact), in groups of four to eight, were placed in sterile dialysis tubing (Spectro/Por 7, 25 K molecular weight cut-off) filled with sterile, control ASW. The ganglia were then dialyzed in 250-300 ml of medium identical to that used for extended perfusion. Dialysis was carried out in a stirred bath at 10~ and the dialysis medium was changed every 24 hr. The ganglia were then removed from the dialysis tubing, and each group was pinned to a 60-cm, Sylgard-lined, plastic petri dish, and the ganglia were desheathed. The plate was then placed under perfusion with control ASW and the giant neuron steady-state I-V curves were measured.
All reagents were of highest grade available. 12-O-tetradecanoylphorbol-13-acetate, indomethacin, 4-bromo-phenacylbromide, nordihydroguaiaritic acid, acetylsalicylic acid, serotonin creatine sulfate and isobutylmethylxanthine were from Sigma. Forskolin was from Calbiochem. DMSO was from Aldrich. Dispase was from Boehringer-Mannheim. Inorganic salts were from Fisher. Fatty acids were from Cayman Chemicals (Ann Arbor, MI).
BIOCHEMISTRY
Methods for analyzing AA metabolism are described in the accompanying paper [11] .
Results
GIANT NEURONS CONTAIN INWARDLY RECTIFYING POTASSIUM CURRENT
Current-v01tage curves in the giant neurons, R2 and LP1, of Aplysia were generated with 0.5-sec voltage steps from a holding potential of -70 to -50 mV, to command potentials from -110 to -40 mV. At rest, the I-V curves exhibited an inwardly rectifying current at potentials more hyperpolarized than -70 mV, which is the potassium equilibrium potential (E~) in Aplysia neurons in ASW (see I-V curves in control ASW in Fig. 1 ). This inwardly rectifying current was abolished in the presence of 0.5 to I mM Ba 2 § (Fig. 1) . Also, lowering the potassium concentration from 10 mM to 2 mM removed the rectifying component of the current (Fig. 1) . These results suggest this conductance is likely an inwardly rectifying potassium current (IR) of the type described previously in Aplysia neurons [6, 22] . IR is blocked selectively by a low concentration of Ba 2+, and is known to rectify inwardly at EK [6, 23, 38] .
We therefore defined IR in giant neurons as the current present at potentials more hyperpolarized than -70 mV that was blocked with 0.5-1 mM Ba 2+. The current not blocked by barium wasdesignated undefined or "leak" current. Leak current measured in the presence of barium was subtracted from I-V curves to isolate IR. This leak subtraction procedure (depicted in Fig. 1A ) was used routinely to identify changes specific to IR. Changes in IR present at potentials more depolarized than -70 mV were not analyzed due to the presence of undefined contaminating currents. To determine the amount of current due to IR in giant neurons at rest, the slope conductance of the I-V curve from -110
to -70 mV was compared before and after exposure to barium in control ASW (example in Fig. 1 ). At rest, IR was found to account for 48 +-2% (n = 32) of the total conductance at voltages more hyperpolarized than EK. This proportion of IR was found to be generally typical of other Aplysia neurons tested (e.g., medial cells of the pleural ganglia, B 1 of the buccal ganglion, and R14 of the abdominal ganglion). A larger amount of resting IR was found only in R15 [6, 33] and left upper quadrant neurons of the abdominal ganglion (this study). . To determine the extent to which the BPB-induced conductance increase was due to a change in IR, the slope conductance (from -110 to -70 mV) was measured for 0.5 mM Ba 2+ alone and Ba 2 § plus BPB. Over 96% of the slope conductance increase induced with 50/~M BPB was inhibited with Ba 2 § Also, the BPB-induced stimulation of IR did not reverse with up to 2.5 hr of perfusion with control ASW (Fig. 2B shows the BPBinduced increase in IR did not reverse with a 70 min wash). BPB is established as an irreversible inactivator of phospholipase A2 [51, 61] , which is consistent with this irreversible stimulation of IR.
To test whether the effect of BPB was directly on the giant neuron, BPB was applied to the giant neuron cell body in a gentle stream flowing by gravity from the broken tip of a microelectrode pipette. The location of the stream was monitored by addition of 0.2% (wt/vol) fast green to the solution in the pipette. By altering the size of the pipette aperture, the stream width could be confined within the dimensions of the giant neuron cell body, and the rate of flow was adjusted to cause the stream to be diluted substantially (as determined by disappearance of the tracking die) within several hundred microm- The labels above the graph depict the following sequence of conditions: control ASW; +50 ~M BPB; +BPB + 0.5 mM Ba2+; BPB alone; control ASW wash MINUTES eters away from the pipette tip. This created a small "plume" of perfusate that could be localized on the giant neuron cell body. Such a plume of BPB-containing perfusate (50-100/aM) was found to stimulate IR in a manner identical to that described for bath-applied BPB (n = 14).
Indomethacin
Indomethacin was also found to increase In in giant neurons (n = 31, examples for 50-150/~M indomethacin in Figs. 3 and 4) . The indomethacin-induced current was inwardly rectifying around E~ (inset graph, Fig. 3A) , and was blocked by Ba 2+ (Figs. 3B and 4), and by lowering potassium from 10 to 2 mN (data not shown). Determined. as described for BPB, 93% of the indomethacin-induced slope conductance increase was due to an increase in IR. Also, as described for BPB, indomethacin was equally effective when its application was confined to the giant neuron cell body (n = 5). However, unlike BPB, the effect of indomethacin was readily reversible when applied by bath (Figs. 3B and 4) or cell-body-localized perfusion. This reversibility allowed a test of the accuracy of cell body perfusion, which proved quite precise. Reversal of the indomethacin-induced stimulation of IR began immediately upon removal of the perfusion plume, even if the plume was simply moved just out of range of the cell body. The dose dependence for the effect of indomethacin on IR is depicted in Fig. 5 . Indomethacin was consistently stimulatory above 10/~M, and this effect saturated by 250/~M. At saturation, IR was increased over fivefold. Also, a saturating dose of indomethacin occluded the effect of BPB, suggesting these agents are acting through the same pathway to modulate IR.
Indomethacin is known to be an inhibitor of cyclooxygenase [20] , which catalyzes the first step for conversion of AA to prostaglandins and thrombox- aries. Acetylsalicylic acid is also known to inhibit cyclooxygenase [20] ; however, we observed no effect of this inhibitor at up to 50/ZM. We also tested the effect of nordihydroguaiaritic acid on IR. NDGA is known to inhibit lipoxygenase catalyzed peroxylation and hydroxylation of AA [63] and has been reported to inhibit this activity in Aplysia [48] .
We did not observe any effect of NDGA on IR at up to 50/z~. In each case, after testing for the effects shown for each condition tested. Recording began under perfusion of 50/z~ indomethacin (due to a previous experiment with indomethacin in an adjacent neuron in the same ganglion). The concentration of indomethacin for perfusion was increased to 100/zM and then to 150 ffM. Approximately 30 rain of perfusion was required to reach a new steady state in inward current for each change; much of this time was required for the bath to attain the new concentration. In the presence of 150/zM indomethacin, the addition of 0.5 mM BaCl2 decreased the inward current by over 73%. Subtraction of the current magnitude at the end of the pulse, with and without Ba 2+, revealed that of the 134 nA of inward current elicited by hyperpolarization in the presence of 150 ~M indomethacin, 98 nA were due to IR. Subsequently, both indomethacin and Ba 2+ were removed by perfusion with control ASW for about 1 hr. After this wash, the steady-state In was reduced to 21 nA out of a total of 57 nA of inward current. The giant neuron was then exposed to 50/~M BPB by perfusion for 1 hr, and the BPB was removed by perfusion with control AWS. Subsequent addition of 0.5 mMBa 2+ inhibited 72% of the inward current. Therefore, of the 147 nA of inward current induced by hyperpoiarization after exposure to BPB (labeled 50 #M BPB), 106 nA due to In, which is a fivefold increase in In relative to control of these inhibitors, a robust effect of either indomethacin or BPB was observed.
Although a saturating dose of indomethacin occluded the effect of BPB on IR, indomethacin did The phorbol ester, TPA, was found to inhibit IR (500 riM, n = 8, example in Fig. 7A ). 500 nM TPA has been shown to stimulate maximally the liberation of AA from phospholipid storage, which increases intracellular free AA and greatly increases the release of free AA and eicosanoids into the extracellular medium [11] . Over 85% of the conductance denot have the same effect as BPB on AA metabolism in Aplysia ganglia. At concentrations up to 250/ZM, indomethacin did not consistently alter the redistribution of radioactivity which occurred with 50 /xM exogenous AA chase. However, indomethacin (250 IzM) was found to inhibit uptake of AA into storage lipids. Figure 6 depicts the uptake of AA from medium containing 0.5 ~M AA (sp act, 40 mCi/ mmol), with and without indomethacin. Uptake into total phospholipid did not show a significant change, while uptake into neutral lipid was inhibited 68%, and the radioactivity in internal free AA was fourfold greater in the presence of indomethacin.
12-O-tetradecanoylphorbol-13-ac etate
crease with TPA was due to inhibition of IR (determined with and without Ba 2+, as described for BPB). This inhibition was on average a 40 -+ 25% reduction of IR at rest and was completely reversible with wash. To see if TPA could inhibit the effect of indomethacin, a ganglion was first exposed to perfusion with TPA, then TPA and indomethacin, and finally indomethacin alone. Steady state I-V curves for each of those conditions are depicted for a representative experiment in Fig. 7B . The stimulatory effect of indomethacin was decreased 64 + 35% in the presence of TPA (n = 4 for 50-60/,M indomethacin and 500 nM TPA), suggesting indomethacin (and BPB, by inference) and TPA are acting through a common pathway to affect IR.
INTERACTION BETWEEN INHIBITORS OF AA METABOLISM AND cAMP
In Aplysia neuron R15, serotonin (5HT) has been shown previously to modulate IR through cAMP [2, 6, 19] . 5HT binds cell surface receptors to activate adenylate cyclase and thereby increase intracellular cAMP, which initiates a cascade of steps leading to an increase in IR. We also found IR in the giant neurons was increased with 5HT, as Gunning [22] reported previously. This stimulatory effect of 5HT was found to saturate at 50/XM.
We were interested in the possibility that the pharmacological agents used in this study were act- ing through the cAMP cascade tO modulate IR. Interaction at the level of the 5HT receptor was addressed first. Saturating 5HT did not block the indomethacin-or BPB-induced increase in IR. In fact, the stimulatory effect of indomethacin was apparently unattenuated in the presence of saturating 5HT (Fig. 8) . These results preclude the 5HT receptor as the site of action of indomethacin, or, by inference, of the other modulators of AA metabolism. However, these agents could be acting at a point downstream from 5HT receptor-linked adenylate cyclase activation. A combination of the adenylate cyclase activator forskolin and the phosphodiesterase inhibitor isobutylmethylxanthine was used to bypass cell surface receptor activation of tent adenylate cyclase activation and phosphodiesterase inhibition, In was still stimulated with indomethacin, suggesting a mechanism of activation of In independent of cAMP metabolism.
DIALYSIS WITH AA AND OTHER FATTY ACIDS
Direct application of AA (up to 50/,s did not consistently produce changes in In. However, longterm incubation in AA was found to inhibit In. Ganglia were placed in dialysis tubing for dialysis in ASW supplemented with a diluted nutrient medium (termed perfusion medium; described in Materials and Methods), either alone, with BSA, or with BSA and 20 ~M AA or other unsaturated fatty acids (at 10~ for 40-46 hr). Following dialysis, the ganglia were desheathed and the inward rectifier conductance of the giant neurons was measured. The mean inward rectifier conductances (expressed as percent of total conductance to normalize for differences in cell sizes) for each condition are compared in Fig.  10 . In the presence of 20/,~M AA, In was inhibited -40% relative to dialysis with BSA alone. However, several other unsaturated fatty acids were equally as effective for inhibition of In, including eicosatrienoic (20:3~o9), eicosapentaenoic (20:5co3), and docosahexaenoic (22:6~o3) acid. Eicosatetraynolc acid (ETYA) and docosatetraenoic acid (22:4co6) were the only fatty acids tested which did not produce a significant change in IR.
EFFECTS OF PROLONGED PERFUSION ON~
TPA and BPB altered In in ways consistent with the activity of these substances on AA metabolism [11] . The fact that BPB had a potent effect on In in the resting state suggested that the constant AA turnover (described in the companion paper [111) may be providing free AA to mediate constitutive inhibition of In. To test this idea, we attempted to deplete the giant neuron of stored AA, reasoning that if AA was involved in inhibition of IR in the resting state, then loss of stored AA might reveal some of this constitutively inhibited In. With the knowledge that AA is continuously released from storage in ganglia, we used extended perfusion with BSA to strip the giant neurons of AA, and tested the effect of this perfusion on the magnitude of In.
Steady-state In was measured in giant neurons in freshly dissected and desheathed ganglia, and then the ganglia were placed under perfusion with perfusion medium for -12 hr. Finally, the ganglia were placed under perfusion with control ASW, and the steady-state In of the giant neurons was measured again. As shown in Fig. 11 , after this protocol with perfusion medium alone, the mean IR was decreased. However, if 0.5 mg/ml BSA was added to the perfusion medium, In was significantly larger after 12 hr of perfusion (Fig. 11) .
To test whether this effect of perfusion with BSA could be due to loss of AA, the protocol was repeated with Perfusion medium containing BSA and 5-10/XM AA. As depicted in Fig. 11 , the addition of AA substantially decreased the stimulatory effect of perfusion with BSA alone. Conversely, we hypothesized that a decrease in phospholipase activity might limit the amount of AA lost and thereby decrease the stimulatory effect of perfusion with BSA. In fact, pretreatment of giant neurons with BPB completely abolished the effect of perfusion with BSA (Fig. 11) . c) c) 9 50 no BSA BSA AA BPB Fig. 11 . The effect of extended perfusion on 1R. Ganglia were prepared for extended perfusion as described in Materials and Methods. Groups of four to eight abdominal and/or left pleuropedal ganglia were pinned out and desheathed on a single plate. The plate was placed under perfusion with sterile, control ASW. The giant neurons were successively placed under voltage clamp (held at -50 mV), the time for the start of voltage clamp for each was noted, and the resting steady-state inward rectifier conductance was measured. This initial conductance was compared to the inward rectifier conductance measured again in the same cell after perfusion for 12 hr with sterile perfusion medium (described in Materials and Methods) alone (blank), or containing 0.05% (wt/vol) BSA (left diagonal), or BSA and 5-10 ~M AA (crosshatch), or with BSA after pretreatment with 100 ~M BPB for 30 min (right diagonal). Inward rectifier conductance for giant neurons treated with BPB was measured initially before exposure to BPB glia. We concluded the constant release of free AA and eicosanoids that accompanied this turnover was too large to be solely the result of futile cycling. Therefore, we hypothesized that the free AA or eicosanoids provided by this constant turnover must have a physiological role. In this paper, we have identified constitutive inhibition of IR as a potential role. This conclusion is based in part upon a correlation between the effects of several pharmacological agents on IR on the one hand, and on AA metabolism on the other. BPB, an inhibitor of AA turnover, activated IR, and TPA, a stimulator of AA turnover, inhibited IR. BPB has been shown to inhibit liberation of AA from phospholipid and decrease internal free AA in Aplysia [11] . At rest, IR was stimulated with BPB, suggesting that inhibition of phospholipase activity and a concomitant decrease in availability of free AA resulted in stimulation of IR. Therefore, resting phospholipase activity must be high enough to provide sufficient free AA to maintain constitutive inhibition of IR, which is revealed in the presence of BPB. Although BPB is a fairly nonspecific alkylating agent, the widespread evidence that BPB is an effective inhibitor of PLA2, both in vivo and in vitro (see accompanying paper [11] for references), supports the likelihood that BPB is acting through this pathway in the giant neurons.
The results with TPA support this model. TPA has been shown to stimulate liberation of AA from phospholipid in Aplysia nervous system and TPA has been shown to inhibit IR. If TPA acts by stimulating phospholipase activity, this means that the resting activity, although high, is not maximal. That is, the resting phospholipase activity is high enough to shut down most, but not all, of the potentially available In. If all of the constitutively inhibited I8 is revealed with a saturating dose of indomethacin, then over 80% of the potentially available In is inhibited at rest.
Indomethacin is often used to selectively inhibit prostaglandin synthesis. Piomelli et al. [48] reported that prostaglandin E2 production in Aplysia nervous system was inhibited by indomethacin with an ICs0 value of 0.5 p~. We found the half maximal concentration for indomethacin-induced stimulation of IR was about 100/~M, which is not consistent with indomethacin acting as selective inhibitor of prostaglandin production as the mechanism for stimulation of IR. High concentrations (100-500 ~ZM) of indomethacin have been shown to inhibit phospholipase activity [21, 25, 34, 50] , diacylglycerol lipase activity [49] and AA uptake [35] . With 250/XM indomethacin (saturating with respect to IR stimulation) we were only able to detect an effect on AA uptake. After two hours incubation in 0.5 /xM AA in the presence of indomethacin, radioactivity in the internal free AA pool was fourfold greater, and uptake into neutral lipid was decreased 68%, while uptake into phospholipid was unchanged. If indomethacin specifically inhibited the fatty-acyl transferase which catalyzes esterification of AA-CoA into neutral lipid (see accompanying paper [11], Fig. 1 , pathway III), we would expect to see an increase in uptake into phospholipid, and a smaller increase in internal free AA than observed. Therefore, specific inhibition of the fatty acyl-CoA synthetase (see accompanying paper [11], Fig. 1 , pathway //) accounts best for the effect of indomethacin. We would expect to see decreased AA-CoA in ganglia commensurate with the magnitude of inhibition of uptake into neutral lipid, a hypothesis soon to be tested. Neufield et al. [44] demonstrated that a mutant cell line lacking synthetase activity specific for AA was also deficient in prostaglandin production and bradykinin-stimulated liberation of AA from phospholipid. Therefore, acyl-CoA synthetase activity can be very important for regulation of free AA and the production of eicosanoids.
The conclusion that indomethacin is not likely acting as a specific cyclooxygenase inhibitor to stimulate IR is supported by the lack of effect of acetylsalicylic acid, another inhibitor of cyclooxygenase. Furthermore, this means prostaglandins are not likely responsible for inhibition of IR. At concentrations from 25-100 /XM, indomethacin has been shown to inhibit both cyclooxygenase and lipoxygenase activity [7, I0, 53, 55, 57] . However, if indomethacin is acting through inhibition of lipoxygenases, the lipoxygenase inhibitor NDGA also should have stimulated IR, but it was found to be ineffective. The available evidence is most consistent with the conclusion that free AA is involved in constitutive inhibition of IR, and that the eicosanoids produced likely have another physiological role.
ALTERING AA IN STORAGE AFFECTS IR
AA has been shown to have direct effects on cellular physiology, particularly with regard to AA-induced mobilization of intracellular calcium [4, 14, 17, 32, 42, 52, 62, 64] . In permeabilized pancreatic islet cells, intracellular calcium was mobilized with AA in a manner similar to that produced by IP3 [60, 62] . Direct application of AA has been shown to activate potassium currents in several systems. In patch-clamp studies of Aplysia sensory neurons,
AA increased the open probability of individual Schannels [48] . Most recently, outwardly rectifying potassium currents of heart and smooth muscle cells under patch clamp were observed to be activated directly by AA and other unsaturated fatty acids [30, 46] .
In addition to the pharmacological evidence, a direct indication of AA involvement in inhibition of IR came from the experiments using extensive perfusion. The observed constitutive release of AA [11] suggested extensive perfusion of ganglia with BSA should remove stored AA, and disinhibit IR.
Such perfusion didin fact increase In, and this stim: ulation was decreased by including AA in the perfusion medium, or by pretreatment with BPB. Paradoxically, extensive perfusion without BSA led to a decrease in IR. We do not know the cause of this; however, we plan to inVestigate the possibility that extensive perfusion may lead to "calcium-loading" due to decreased membrane resistance. Extensive perfusion was often observed to increase the leak current in the giant neuron (data not shown). The increase in intracellular calcium which likely accompanies the increased leak current could activate phospholipase, leading to an increase in internal free AA and inhibition of IR.
The effect of BPB on the perfusion-induced activation of IR was determined by comparing inward rectifier conductance before exposure to BPB to the conductance after BPB pretreatment and perfusion with BSA for -12 hr. Like perfusion with no BSA, the inward rectifier conductance in giant neurons treated with BPB was actually smaller after overnight perfusion with BSA. Again, we cannot explain this phenomenon, but BPB clearly prevents any increase in conductance, consistent with inhibition of phospholipase.
Exogenous AA did not affect IR when applied acutely during electrophysiological recording, consistent with the finding that exogenous AA did not increase the apparent size of the internal free AA pool [1 I]. Kim and Clapham also found that AA was ineffective for activation of an atrial potassium channel when added extracellularly or added to the pipette in cell-attached patches; this potassium channel was activated only with application of AA to inside-out patches [30] . However, we found that IR was smaller after extensive dialysis in AA-containing medium. With AA, inhibition of IR was observed after 24 hr of dialysis (data not shown), although the inhibition was more significant after -40 hr. This time dependence may be explained by a gradual increase in the size of the AA storage pools with dialysis, which may lead to elevated internal free AA and inhibition of IR. Cells in culture have been shown to slowly increase the AA content of lipids when excess AA is available in the medium [59] . McGee et al. [41] recently reported that enrichment of phospholipids with AA altered the gating kinetics of a delayed rectifier potassium channel in a neuroblastoma x glioma cell line.
IR was also found to be decreased after dialysis with other polyunsaturated fatty acids. These fatty acids were chosen for testing because of their similarity to AA, based upon their ability to undergo catalysis or compete with AA for catalysis by eicosanoid-producing enzymes [9, 18, 37] , and because of their reported presence in Aplysia nervous system [48] . Therefore, although AA may not exclusively mediate inhibition OfIR, the predominance of AA in phospholipids in Aplysia relative to the other fatty acids tested [48] suggests AA likely has the most significant physiological role.
AA-AND cAMP-MEDIATED MODULATION OF 117
The cAMP-mediated activation and AA-mediated inhibition of IR that we report is reminiscent of findings for the serotonin-sensitive potassium current 
